Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?

Sexually Transmitted Infections

Volumn 86, Issue 1, 2010, Pages 74-78

  Licht, Andrea S ^a   Murphy, Jill M ^b   Hyland, Andrew J ^a,c   Fix, Brian V ^a   Hawk, Larry W ^c,d   Mahoney, Martin C ^a,c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; TREATMENT RESPONSE; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION PROGRAMS; NEW YORK; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; STUDENTS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77449109931     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.037705     Document Type: Article

References (23)

1. Xi L, Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
2. Baseman J, Koutsky L. The epidemiology of human papilomavirus infections. J Clin Virol 2005;32(Suppl):S16-24.
3. Dunne E, Unger E, Sternber M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813- 19.
4. Centers for Disease Control and Prevention. HPV vaccine information for young women: why the HPV vaccine is important. http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine-young-women.htm (accessed 30 July 2009).
5. Mahoney M. Protecting our patients from HPV and HPV-related diseases: the role of vaccines. J Fam Pract 2006(Suppl):10e17.
6. Tiro J, Meissner H, Korbin S, et al. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev 2007;16:288-94.
7. Friedman A, Shepeard H. Exploring the knowledge, attitudes, beliefs and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 2007;34:471-85.
8. Kahn J, Rosenthal S, Hamann T, et al. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003;14:300-6.
9. Gerend M, Magloire Z. Awareness, knowledge and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 2008;42:237-42.
10. Gerend M, Lee S, Shepherd J. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007;34:468-71.
11. Allen J, Mohllajee A, Shelton R, et al. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009;48:420-5.
12. Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 2008;57:23-31.
13. Boehner C, Howe S, Bernstein D, et al. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003;30:774-8.
14. Merck Pharmaceuticals. Gardasil: full perscribing information, 2006. http://www. merck.com/product/usa/pi-circulars/g/gardasil/gardasil-pi.pdf (accessed 30 July 2009).
15. GlaxoSmithKline. New data show cervarix, GSL's HPV 16/18 cervical cancer candidate vaccine is highly immunogenic and well tolerated in women over 25 years of age. https://us.gsk.com/controllerservlet?appId=4&pageId= 402&newsid=911 (accessed 30 July 2009).
16. Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007;56(RR-2):1-24.
17. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57:1100-3.
18. Centers for Disease Control and Prevention. Vaccine coverage among U.S. adults: national immunization survey-adult, 2007. http://www.cdc.gov/ vaccines/ stats-surv/nis/downloads/nis-adult-summer-2007.pdf (accessed 30 July 2009).
19. Kahn J, Rosenthal S, Jin Y, et al. Rates of human papillomavirus vaccination, attitudes about vaccination and human papillomavirus prevalence in young women. Obstet Gynecol 2008;111:1103-10.
20. Brewer N, Fazekas K. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007;45:107-14.
21. Herzog T, Huh W, Downs L, et al. Initial lessons learned in HPV vaccination. Gynecol Oncol 2008;109(Suppl 2):S4-11.
22. Keating K, Brewer N, Gottlieb S, et al. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health 2008;43(Suppl):S61-7.
23. Reidesel J, Rosenthal S, Zimet G, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005;18: 391-8.